Full Answer
Z79- Long term (current) drug therapy Z79.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2021 edition of ICD-10-CM Z79.1 became effective on October 1, 2020. This is the American ICD-10-CM version of Z79.1 - other international versions of ICD-10 Z79.1 may differ.
When a type 2 excludes note appears under a code it is acceptable to use both the code (Z79) and the excluded code together. drug abuse and dependence ( ICD-10-CM Diagnosis Code F11 drug use complicating pregnancy, childbirth, and the puerperium ( ICD-10-CM Diagnosis Code O99.32
Long term (current) use of opiate analgesic. The 2019 edition of ICD-10-CM Z79.891 became effective on October 1, 2018. This is the American ICD-10-CM version of Z79.891 - other international versions of ICD-10 Z79.891 may differ.
Z20.6, bolded below, is classified as an “acceptable principal diagnosis” in the ICD-10-CM system. Always include Z20.6 when coding PrEP or PEP visits. If an insurer requires additional coding clarifying a patient’s risk, Z20.2 (sexual exposure risk) and F19.20 (injection drug use exposure risk) can be added.
Long term (current) drug therapy Z79- 1 drug abuse and dependence (#N#ICD-10-CM Diagnosis Code F11#N#Opioid related disorders#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#F11 -#N#ICD-10-CM Diagnosis Code F19#N#Other psychoactive substance related disorders#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#Includes#N#polysubstance drug use (indiscriminate drug use)#N#F19) 2 drug use complicating pregnancy, childbirth, and the puerperium (#N#ICD-10-CM Diagnosis Code O99.32#N#Drug use complicating pregnancy, childbirth, and the puerperium#N#2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code#N#Use Additional#N#code (s) from F11 - F16 and F18 - F19 to identify manifestations of the drug use#N#O99.32-)
Z79.02 Long term (current) use of antithrombotics/antiplatelets. Z79.1 Long term (current) use of non-steroidal anti-inflammatories (NSAID) Z79.2 Long term (current) use of antibiotics. Z79.3 Long term (current) use of hormonal contraceptives. Z79.4 Long term (current) use of insulin.
A type 2 excludes note indicates that the condition excluded is not part of the condition it is excluded from but a patient may have both conditions at the same time. When a type 2 excludes note appears under a code it is acceptable to use both the code ( Z79) and the excluded code together. drug abuse and dependence (.
Long term current use of leflunomide (arava) Long term current use of lenalidomide (revlimid) Long term current use of lithium. Long term current use of medication for add and or adhd. Long term current use of medication for attention deficit disorder (add) or attention deficit hyperactivity disorder (adhd)
Opioid dependence (severe use disorder) on agonist therapy, in sustained remission. Opioid dependence, moderate use, on agonist therapy, in early remission. Opioid dependence, moderate use, on agonist therapy, in sustained remission. Opioid dependence, severe use on agonist therapy, in early remission.
The ICD-10 section that covers long-term drug therapy is Z79, with many subsections and specific diagnosis codes. Because Plaquenil does not have its own specific category, clinicians should use Z79.899—Other Long Term (Current) Drug Therapy.
If maculopathy is present, report the adverse effect of the hydroxychloroquine as well: T37.2x5A: Adverse effect of anti-malarials and drugs acting on other blood protozoa, initial encounter. T37.2x5D: Adverse effect of anti-malarials and drugs acting on other blood protozoa, subsequent encounter.
When coding for these individuals, it is important to understand the mechanism in place. The patient is taking a long-term medication for a specific systemic condition, such as rheumatoid arthritis (RA), so the first step is coding for that. This is where communication with other physicians is paramount. You and the patient’s other providers need to remain consistent with the ICD-10 code used to describe the condition for which the patient is being treated. Once you know the primary systemic condition, you can code the medication use and any adverse effects that require further attention.
P atients taking Plaquenil (hydroxychloroquine, Sanofi-Aventis) on a long-term basis may leave you scratching your head when it comes to coding the patient encounters. Although coding for long-term medications is not a difficult process, it often involves communicating with other physicians or specialists to obtain accurate information.